Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1347567

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1347567

Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Market Overview:

The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.

Molecular Diagnostics Market Trends:

Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.

Breakup by Product:

Reagents and Kits

Instruments

Software and Services

Breakup by Technology:

Polymerase Chain Reactions (PCR)

Hybridization

DNA Sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases Diagnostics

Oncology

Genetic Testing

Blood Screening

Others

Breakup by End Users:

Hospitals

Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112023A5726

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genetic Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Screening
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerieux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Hologic Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Qiagen
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quidel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
Product Code: SR112023A5726

List of Figures

  • Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
  • Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
  • Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
  • Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Molecular Diagnostics Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!